Type 2 diabetes trials in China

In China 189 Also abroad 1200

189 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 4Taking people
A Research Study Looking at Kidney and Heart Health in Adults With Type 2 Diabetes and Chronic Kidney Disease Treated With Semaglutide in China
Where
Anyang, Baotou, Beijing, Changchun, Changzhou, Chengdu, Dalian, Fuyang, Huizhou, Jinan, Lanzhou, Linhai, Nanjing, Ningbo, Panjin, Pingxiang, Shanghai, Shantou, Shijiazhuang, Siping, Xining, Yibin, Yichang, Zhenjiang
Age
18 years and over
People
300
Run by
Novo Nordisk A/S
See details and how to joinNCT07900438
No phaseTaking people
AI-Driven Metabolic Cohort in Overweight/Obese Chinese Adults
Where
Guangzhou
Age
18 years to 60 years
People
2,800
Run by
Zhujiang Hospital
See details and how to joinNCT07584330
Phase 3Taking people
A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
Where
Changsha, Hefei, Huai'an, Langfang, Liangyugang, Luoyang, Nanjing, Nanyang, Pinggu, Pingxiang, Shijiazhuang, Tianjin, Yueyang
Age
18 years and over
People
1,200 worldwide
Run by
AstraZeneca
See details and how to joinNCT07662213 · EU 2025-523933-24-00
No phaseNot yet taking people in China
Impact of AI-Based Breath Ammonia Kidney Function Results on Clinical Pharmacist Medication Recommendations
Where
Shanghai
Age
18 years and over
People
380
Run by
Shanghai Pudong Hospital
See details and how to joinNCT07888855
No phaseNot yet taking people in China
Chinese Overweight/Obesity Cohort: Metabolic & Comorbidity Risks
Where
Taiyuan
Age
18 years to 79 years
People
25,974
Run by
Shanxi Bethune Hospital
See details and how to joinNCT07884903
No phaseNot yet taking people in China
Preventive Effectiveness of Primary Care Physician-led CGM-supported Comprehensive Intervention on Cardio-metabolic-immune Diseases in Community Patients With Type 2 Diabetes (Community Diabetes Control Project)
Where
Changsha
Age
18 years to 80 years
People
15,400
Run by
Xiangya Hospital of Central South University
See details and how to joinNCT07885904
Phase 3Taking people
A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
Where
Binzhou, Chengdu, Deyang, Ganzhou, Guangzhou, Haikou, Hangzhou, Huaian, Huzhou, Jinan, Jinzhou, Kunming, Lanzhou, Linhai, Liuzhou, Luoyang, Nanchang, Nanjing, Nantong, Ningbo, Panjin, Pingxiang, Qingdao, Shanghai, Shenyang, Shenzhen, Siping, Suining, Suzhou, Ürümqi, Wanzhou, Wenzhou, Wuhan, Wuxi, Xiangyang, Xuancheng, Yibin, Yichang, Zhengzhou, Zhenjiang, Zunyi
Age
18 years and over
People
4,500 worldwide
Run by
AstraZeneca
See details and how to joinNCT07667803
Phase 3Taking people
A Study of BGM0504 in Early T2DM With Obesity
Where
Nanjing
Age
18 years to 75 years
People
372
Run by
BrightGene Bio-Medical Technology Co., Ltd.
See details and how to joinNCT07743983
Phase 2Not yet taking people in China
A Study of VCT220 Tablets in Adults With Type 2 Diabetes and Inadequate Blood Glucose Control
Where
Beijing
Age
18 years to 65 years
People
120
Run by
Vincentage Pharma Co., Ltd
See details and how to joinNCT07872436
Early phase 1Taking people
Efficacy and Safety of Sanggua Tablets in the Treatment of Patients With Impaired Glucose Tolerance and Mild Type 2 Diabetes
Where
Wuhan
Age
18 years to 70 years
People
84
Run by
Tongji Hospital
See details and how to joinNCT06964620
Phase 2Not yet taking people in China
A Study of HRS-4729 Injection in Participants With Type 2 Diabetes
Where
Tianjin, Wuhan
Age
18 years to 65 years
People
240
Run by
Fujian Shengdi Pharmaceutical Co., Ltd.
See details and how to joinNCT07843862
Phase 1Not yet taking people in China
A Study on the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HRS-1596 Tablets in Healthy Participants With a Single Dose and in Obese Participants With Multiple Doses
Where
Jinan
Age
18 years to 55 years
People
122
Run by
Fujian Shengdi Pharmaceutical Co., Ltd.
See details and how to joinNCT07841860
No phaseTaking people
A Clinical Study on Using Multimodal Ultrasound to Assess Muscle Mass in Metabolic Diseases
Where
Zhangzhou
Age
18 years and over
People
320
Run by
Zhangzhou Municipal Hospital
See details and how to joinNCT07836088
Phase 3Taking people
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
Where
Beijing, Chengdu, Guangzhou, Hefei, Jinan, Luoyang Shi, Nanchang, Nanjing, Shanghai
Age
18 years and over
People
1,980 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07321886 · EU 2025-523657-34-00
No phaseNot yet taking people in China
A Multicenter Randomized Double-Blind Trial of Chrocare CDSS for Integrated Management of Type 2 Diabetes
Where
Shanghai
Age
18 years and over
People
1,200
Run by
Shanghai Jiao Tong University School of Medicine
See details and how to joinNCT07833228
No phaseTaking people
Incidence and Clinical Features of Breakthrough Pain After Brachial Plexus Block in Diabetic Patients
Where
Taiyuan
Age
18 years to 80 years
People
216
Run by
Second Hospital of Shanxi Medical University
See details and how to joinNCT07833930
No phaseTaking people
The Cognitive Protective Effect of VR-based Cognitive Training in Type 2 Diabetes Patients With Mild Cognitive Impairment
Where
Nanjing
Age
45 years to 80 years
People
40
Run by
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
See details and how to joinNCT07650318
No phaseTaking people
Human Genes and Microbiota in Early Life
Where
Guangzhou
People
20,000
Run by
Guangzhou Women and Children's Medical Center
See details and how to joinNCT06926166
Phase 1Taking people
A Single-Dose Pharmacokinetic Study of HRS-4729 Injection in Healthy Participants and Patients With Renal Impairment
Where
Chengdu
Age
18 years to 65 years
People
32
Run by
Fujian Shengdi Pharmaceutical Co., Ltd.
See details and how to joinNCT07807059
No phaseEnrolling by invitation
Research Study to Examine Blood Sugar Control, Treatment Satisfaction and Adherence in People With Type 2 Diabetes After Switching From Daily Basal Insulin to Once-weekly Insulin Icodec
Where
Beijing, Chongqing, Harbin, Huai'an, Jiangmen, Jinan, Langfang, Lanzhou, Nanchang, Nanjing, Shanghai, Shenyang, Shiyan, Suzhou, Urumuqi
Age
18 years and over
People
216
Run by
Novo Nordisk A/S
See details and how to joinNCT07658417
Phase 3Taking people
Phase III Study of UBT251 Injection in Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Diet and Exercise Alone（UNIGUIDE-1）
Where
Changsha
Age
18 years to 75 years
People
360
Run by
The United Bio-Technology (Hengqin) Co., Ltd.
See details and how to joinNCT07659574
Phase 4Taking people
Intervention for High-normal Blood Pressure in Adults With Type 2 Diabetes
Where
Guangzhou
Age
45 years to 79 years
People
11,414
Run by
XueQing Yu
See details and how to joinNCT03264352
Phase 3Taking people
Phase III Study of UBT251 Injection in Patients With Type 2 Diabetes With Inadequate Glycemic Control on Metformin ± Sulfonylurea/SGLT2 Inhibitor Therapy (UNIGUIDE-2)
Where
Shanghai
Age
18 years to 75 years
People
956
Run by
The United Bio-Technology (Hengqin) Co., Ltd.
See details and how to joinNCT07653477
Phase 4Taking people
Fingolimod for Type 2 Diabetes Mellitus
Where
Shenyang
Age
18 years to 70 years
People
40
Run by
General Hospital of Shenyang Military Region
See details and how to joinNCT05307731
Phase 2Taking people
Phase 2 Clinical Study of MWN109 Tablets in Participants With Type 2 Diabetes Mellitus
Where
Beijing
Age
18 years to 75 years
People
240
Run by
Shanghai Minwei Biotechnology Co., Ltd
See details and how to joinNCT07801820